One such scoring method is the Allred scoring system4 for Estrogren Receptor (ER) and Progresterone Receptor (PR), which specifies numerical values for the intensity and the proportion of tumour nuclei stained with the ER or PR marker. The gene discussed is ESR1; the disease is neoplasm.